false
Catalog
The Treatment of Bipolar Depression: From Pills to ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document provides information on the treatment of bipolar depression. It outlines the Clinical Support System for Serious Mental Illness (CSS-SMI), a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and implemented by the American Psychiatric Association (APA). The document also includes information on continuing education credits for physicians and nurses, presentation Q&A, and speaker disclosures.<br /><br />The document discusses the prevalence and impact of bipolar depression, including the high rates of suicide among bipolar patients. It explains the differences between bipolar depression and unipolar depression, and highlights the importance of developing a comprehensive treatment plan.<br /><br />Various treatment options are discussed, including mood stabilizers (such as lithium, valproate, carbamazepine, and lamotrigine), antidepressants, and second-generation antipsychotics (such as quetiapine, olanzapine, lurasidone, and cariprazine). The document presents the findings of studies on the efficacy and tolerability of these medications.<br /><br />Psychotherapy is also discussed as an important component of treatment for bipolar depression. Cognitive behavioral therapy, family focused therapy, and interpersonal and social rhythm therapy are highlighted as evidence-based psychotherapies for bipolar depression.<br /><br />The document concludes by emphasizing the need for a balanced approach to medication selection, considering short-term and long-term efficacy, tolerability, and accessibility. It suggests a treatment algorithm starting with mood stabilizers, followed by additional medications or psychotherapy as needed. The importance of addressing psychological themes related to bipolar depression is also highlighted.<br /><br />Overall, the document provides a comprehensive overview of the treatment of bipolar depression, including medications, psychotherapy, and the importance of a personalized treatment plan.
Keywords
bipolar depression
Clinical Support System for Serious Mental Illness
mood stabilizers
antidepressants
psychotherapy
efficacy
tolerability
treatment algorithm
personalized treatment plan
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English